Karen E Elkind-Hirsch (Karen Elkind-Hirsch)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 3

Top Topics

Placebo Controlled

Polycystic Ovary Syndrome

Top Venues

Experimental biology and medicine (Maywood, N.J.)

The Journal of clinical endocrinology and metabolism

JMIR mHealth and uHealth

This page only lists publications with an associated author ORCID identifier.

Publications

Luan D Vu, Shonta Wallace, Anh Tq Phan, Rebecca C Christofferson, Erik A Turner, Sean Parker, Karen E Elkind-Hirsch, Darrell Landry, Austin Stansbury, Rebecca Rose, David J Nolan, Susanna L Lamers, Michael Hirezi, Beverly Ogden, Stephania A Cormier
Absence of antibody responses to SARS-CoV-2 N protein in COVID-19 vaccine breakthrough cases. Experimental biology and medicine (Maywood, N.J.) (2022)
Karen E Elkind-Hirsch, N Chappell, Ericka Seidemann, John Storment, Drake Bellanger
Exenatide, Dapagliflozin, or Phentermine/Topiramate Differentially Affect Metabolic Profiles in Polycystic Ovary Syndrome. The Journal of clinical endocrinology and metabolism 106 (10) (2021)
Leanne Maree Redman, Linda Anne Gilmore, Jeffrey Breaux, Diana M Thomas, Karen E Elkind-Hirsch, Tiffany M Stewart, Daniel S Hsia, Jeffrey Burton, John W Apolzan, Loren E Cain, Abby D Altazan, Shelly Ragusa, Heather Brady, Allison Davis, J Mick Tilford, Elizabeth F Sutton, Corby K Martin
Effectiveness of SmartMoms, a Novel eHealth Intervention for Management of Gestational Weight Gain: Randomized Controlled Pilot Trial. JMIR mHealth and uHealth 5 (9) (2017)